HLB Co. Ltd (028300) - Total Assets
Based on the latest financial reports, HLB Co. Ltd (028300) holds total assets worth ₩925.44 Billion KRW (≈ $627.16 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can HLB Co. Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
HLB Co. Ltd - Total Assets Trend (2005–2025)
This chart illustrates how HLB Co. Ltd's total assets have evolved over time, based on quarterly financial data. See HLB Co. Ltd shareholders equity for net asset value and shareholders' equity analysis.
HLB Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
HLB Co. Ltd's total assets of ₩925.44 Billion consist of 13.4% current assets and 86.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 4.4% |
| Accounts Receivable | ₩9.52 Billion | 1.0% |
| Inventory | ₩9.45 Billion | 1.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩255.82 Billion | 27.5% |
| Goodwill | ₩77.83 Billion | 8.4% |
Asset Composition Trend (2005–2025)
This chart illustrates how HLB Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of HLB Co. Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: HLB Co. Ltd's current assets represent 13.4% of total assets in 2025, an increase from 0.0% in 2005.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2025, down from 17.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 35.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 27.5% of total assets.
HLB Co. Ltd Competitors by Total Assets
Key competitors of HLB Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Akero Therapeutics Inc
NASDAQ:AKRO
|
USA | $1.01 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Zealand Pharma A/S
CO:ZEAL
|
Denmark | Dkr16.46 Billion |
|
Verona Pharma PLC ADR
NASDAQ:VRNA
|
USA | $572.87 Million |
|
Immunitybio Inc
NASDAQ:IBRX
|
USA | $518.99 Million |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
China | CN¥6.66 Billion |
HLB Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.28 | 0.67 | 2.34 |
| Quick Ratio | 0.24 | 0.61 | 2.27 |
| Cash Ratio | 0.00 | 0.31 | 2.03 |
| Working Capital | ₩-252.75 Billion | ₩-65.80 Billion | ₩123.69 Billion |
HLB Co. Ltd - Advanced Valuation Insights
This section examines the relationship between HLB Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.48 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4.8% |
| Total Assets | ₩930.18 Billion |
| Market Capitalization | $2.76 Billion USD |
Valuation Analysis
Below Book Valuation: The market values HLB Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: HLB Co. Ltd's assets grew by 4.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for HLB Co. Ltd (2005–2025)
The table below shows the annual total assets of HLB Co. Ltd from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩930.18 Billion ≈ $630.37 Million |
+4.82% |
| 2024-12-31 | ₩887.42 Billion ≈ $601.40 Million |
+18.05% |
| 2023-12-31 | ₩751.72 Billion ≈ $509.43 Million |
-22.28% |
| 2022-12-31 | ₩967.27 Billion ≈ $655.50 Million |
+30.06% |
| 2021-12-31 | ₩743.69 Billion ≈ $503.99 Million |
+5.27% |
| 2020-12-31 | ₩706.48 Billion ≈ $478.77 Million |
+94.83% |
| 2019-12-31 | ₩362.61 Billion ≈ $245.74 Million |
+19.26% |
| 2018-12-31 | ₩304.04 Billion ≈ $206.04 Million |
+61.56% |
| 2017-12-31 | ₩188.19 Billion ≈ $127.54 Million |
+0.80% |
| 2016-12-31 | ₩186.71 Billion ≈ $126.53 Million |
+0.83% |
| 2015-12-31 | ₩185.17 Billion ≈ $125.49 Million |
+241.32% |
| 2014-12-31 | ₩54.25 Billion ≈ $36.77 Million |
+50.27% |
| 2013-12-31 | ₩36.10 Billion ≈ $24.47 Million |
-5.60% |
| 2012-12-31 | ₩38.24 Billion ≈ $25.92 Million |
-29.51% |
| 2011-12-31 | ₩54.25 Billion ≈ $36.76 Million |
-6.64% |
| 2010-12-31 | ₩58.11 Billion ≈ $39.38 Million |
-28.68% |
| 2009-12-31 | ₩81.48 Billion ≈ $55.22 Million |
+16.90% |
| 2008-12-31 | ₩69.70 Billion ≈ $47.23 Million |
+45.04% |
| 2007-12-31 | ₩48.05 Billion ≈ $32.56 Million |
+48.89% |
| 2006-12-31 | ₩32.27 Billion ≈ $21.87 Million |
+30.35% |
| 2005-12-31 | ₩24.76 Billion ≈ $16.78 Million |
-- |
About HLB Co. Ltd
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, inclu… Read more